Sanofi advances NK cell engager to Phase II for blood cancer treatment
The asset is part of a research collaboration and license agreement with Innate Pharma.
The asset is part of a research collaboration and license agreement with Innate Pharma.
The study will assess the economic and healthcare outcome benefits of Acarix's AI-powered CADScor System compared to traditional stress test.
The pharmaceutical industry continues to be a hotbed of patent innovation. Activity is driven by the evolution of new treatment...
Cleerly touts new data for AI cardiovascular software
Moderna’s Phase III Covid-19 vaccine trial meets primary endpoints
Gedeon Richter adopts TransPerfect’s trial management solutions
Artificial intelligence identified two evolutionary pathways of prostate cancer